Maryland Oncology Hematology — Columbia, Maryland

Public research footprint of Maryland Oncology Hematology, compiled from the ClinicalTrials.gov public registry.

111

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Carcinoma, Non-Small-Cell Lung · Stage IIIA Lung Non-Small Cell Cancer AJCC v7 · Melanoma · Breast Cancer

Recently updated registry entries

NCT01274338 — Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage… (Active Not Recruiting)
NCT00310180 — Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have… (Active Not Recruiting)
NCT06623422 — A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Maryland Oncology Hematology?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.